DEBT (Details) - USD ($)
|
|
3 Months Ended |
|
|
Dec. 01, 2015 |
May 31, 2021 |
Apr. 01, 2021 |
Feb. 28, 2021 |
| DEBT (Details) [Line Items] |
|
|
|
|
| Long-term Debt |
|
$ 14,738,500
|
|
|
| Long-term Line of Credit |
|
8,732,500
|
|
$ 5,245,300
|
| Notes Payable |
|
$ 3,896,200
|
|
0
|
| Line of Credit [Member] |
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
| Line of Credit Facility, Expiration Date |
|
Aug. 15, 2022
|
|
|
| Debt Instrument, Interest Rate, Basis for Effective Rate |
|
interest payable monthly at the Bank-adjusted LIBOR Index plus a tiered pricing rate based on the Company’s Adjusted Funded Debt to EBITDA Ratio, with a minimum rate of 2.75% (the effective rate was 2.75%
|
|
|
| Line of Credit Facility, Interest Rate at Period End |
|
2.75%
|
|
|
| Long-term Line of Credit |
|
$ 8,732,500
|
|
5,245,300
|
| Line of Credit Facility, Remaining Borrowing Capacity |
|
6,267,500
|
|
9,570,200
|
| Tranche A [Member] | Notes Payable to Banks [Member] |
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
| Line of Credit Facility, Maximum Borrowing Capacity |
$ 13,400,000
|
|
|
|
| Debt Instrument, Interest Rate During Period |
4.23%
|
|
|
|
| Line of Credit Facility, Expiration Date |
Dec. 01, 2025
|
|
|
|
| Debt Instrument, Interest Rate, Stated Percentage |
|
|
3.12%
|
|
| Long-term Debt |
|
10,842,300
|
|
$ 10,984,700
|
| Term Loan # 2 [Member] | Line of Credit [Member] |
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
| Line of Credit Facility, Maximum Borrowing Capacity |
|
$ 15,000,000.0
|
|
|
| Advancing Term Loan [Member] |
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
| Debt Instrument, Interest Rate During Period |
|
2.75%
|
|
|
| Debt Instrument, Face Amount |
|
$ 6,000,000.0
|
|
|
| Debt Instrument, Interest Rate Terms |
|
The Advancing Term Loan requires interest-only payments through July 15, 2021, at which time it will convert to a 60-month amortizing term loan maturing July 15, 2026. The Advancing Term Loan accrues interest at the Bank-adjusted LIBOR Index plus a tiered pricing rate based on the Company’s Adjusted Funded Debt to EBITDA Ratio, with a minimum rate of 2.75% (the effective rate was 2.75%
|
|
|
| Notes Payable |
|
$ 3,896,200
|
|
|
| Tranche B [Member] | Notes Payable to Banks [Member] |
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
| Debt Instrument, Interest Rate, Basis for Effective Rate |
|
Term Loan and the line of credit accrue interest at a tiered rate based on our Adjusted Funded Debt to EBITDA ratio.
|
|
|